| | | |   | | | | By Ed Silverman NIAID The decision not to pursue voluntary licenses for the HIV prevention shot is a “disgraceful change in practice," advocacy groups said. Read More | | By Rachel Cohrs Pfizer Disputes over the White House's lack of transparency are imperling its efforts to get more Covid-19 relief money. Read More | | By Ed Silverman Adobe A treaty was one of seven recommendations made by a National Academies of Sciences committee to improve the supply chain. Read More | | Sponsor content by Otsuka America Pharmaceutical, Inc. Kidney size is a leading indicator for progression of a rare disease When prioritizing topics of conversation for a doctor's visit, kidney size may not be at the top of most people's lists. However, for those with a family history of kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), actively monitoring the size of this vital organ is among the most important things to address. Patients and those interested in starting an informed conversation about ADPKD can visit ADPKDQuestions.com. | | By Jonathan Wosen Ashley Waters for STAT Black entrepreneurs cite everything from unconscious bias by investors and colleagues to limited access to helpful networks and resources. Read More | |
No comments